Exploring the Potential of Glia for Regulating Clinically Relevant Opiod Actions
探索神经胶质细胞调节临床相关阿片类药物作用的潜力
基本信息
- 批准号:7768258
- 负责人:
- 金额:$ 7.17万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-02-01 至 2013-01-31
- 项目状态:已结题
- 来源:
- 关键词:Adverse effectsAnalgesicsAnimal WelfareAstrocytesBibliographyBlood - brain barrier anatomyBrainClinicalCountryDataDependenceDevelopmentDoseDrug usageEmployee StrikesEnvironmentEnvironmental ImpactEquipmentExposure toFibrinogenGoalsIACUCInternationalInvestigationKnowledgeLaboratoriesMediatingMicrogliaMorphineMorphine DependenceNaloxoneNeurogliaNeuronsOpiate AddictionOpioidOpioid ReceptorPainPharmaceutical PreparationsPhysiologicalPlayPrincipal InvestigatorRegulationRelative (related person)ResearchResearch Ethics CommitteesResourcesRewardsRoleSpinalSpinal CordStagingStimulusSubstance Withdrawal SyndromeTestingUnited StatesUp-RegulationVertebratesWithdrawalabstractingaddictioncell typeclinically relevantcytokinedrug cravingexpirationhigh riskhuman subjectinhibitor/antagonistneurochemistrynovelopioid abusephrasespreventprogramsrelating to nervous system
项目摘要
It has recently been discovered that glia become progressively more activated upon repeated exposure to morphine, & that this glial activation, in turn, modulates morphine's effects. This discovery was originally made in the context of studying the pain suppressive effects of morphine in spinal cord. The possibility that glia may be fundamentally important in determining the effects of opioids such as morphine is novel & important in its implications. Because of this, we propose to explore whether glia may profoundly alter the effects of repeated morphine in brain, as well. We believe that glia will prove to be powerfully involved in several phenomena currently thought to arise purely as a result of opioid effects on neurons; that is, dependence/withdrawal, reward & aversion. If this were true, it would provide evidence that glia are critically involved, not only in modulating the pain-suppressive effects of opioids, but also in
最近发现,神经胶质细胞在反复接触吗啡后变得越来越活跃,这种神经胶质细胞的激活反过来又调节了吗啡的作用。这一发现最初是在研究吗啡在脊髓中的疼痛抑制作用时发现的。胶质细胞在决定阿片类药物(如吗啡)的作用方面可能具有根本性的重要性,这种可能性是新颖的,其意义也是重要的。正因为如此,我们建议探索胶质细胞是否也会深刻地改变大脑中重复吗啡的作用。 我们相信,胶质细胞将被证明是强大的参与几种现象,目前认为纯粹是由于阿片类药物对神经元的影响而产生的;即依赖/撤回,奖励和厌恶。如果这是真的,它将提供证据表明,胶质细胞不仅在调节阿片类药物的疼痛抑制作用中起着关键作用,而且在调节阿片类药物的疼痛抑制作用中也起着关键作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
LINDA WATKINS其他文献
LINDA WATKINS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('LINDA WATKINS', 18)}}的其他基金
Enduring enhancement of neuropathic pain by early post-trauma morphine
创伤后早期吗啡持久增强神经性疼痛
- 批准号:
9906887 - 财政年份:2018
- 资助金额:
$ 7.17万 - 项目类别:
Enduring enhancement of neuropathic pain by early post-trauma morphine
创伤后早期吗啡持久增强神经性疼痛
- 批准号:
10393512 - 财政年份:2018
- 资助金额:
$ 7.17万 - 项目类别:
Targeting toll like receptor 4 (TLR4) and TLR2 to resolve EAE-associated paralysis, pain and cognitive deficits: efficacy of a clinically-relevant blood brain barrier permeable TLR4/TLR2 antagonist
靶向 Toll 样受体 4 (TLR4) 和 TLR2 以解决 EAE 相关的麻痹、疼痛和认知缺陷:临床相关血脑屏障可渗透性 TLR4/TLR2 拮抗剂的功效
- 批准号:
9153350 - 财政年份:2016
- 资助金额:
$ 7.17万 - 项目类别:
Targeting neuropathic pain prevention: Modulating the neuroimmunology of peripheral nerve injury
以预防神经病理性疼痛为目标:调节周围神经损伤的神经免疫学
- 批准号:
10062833 - 财政年份:2016
- 资助金额:
$ 7.17万 - 项目类别:
Spinal adenosine modulator: enduring anti-inflammatory action in neuropathic pain
脊髓腺苷调节剂:对神经性疼痛具有持久的抗炎作用
- 批准号:
7805660 - 财政年份:2009
- 资助金额:
$ 7.17万 - 项目类别:
Spinal adenosine modulator: enduring anti-inflammatory action in neuropathic pain
脊髓腺苷调节剂:对神经性疼痛具有持久的抗炎作用
- 批准号:
7937819 - 财政年份:2009
- 资助金额:
$ 7.17万 - 项目类别:
Models and mechanisms for the transition of acute-to-chronic orofacial pain
急性至慢性口面部疼痛转变的模型和机制
- 批准号:
7936108 - 财政年份:2009
- 资助金额:
$ 7.17万 - 项目类别:
Models and mechanisms for the transition of acute-to-chronic orofacial pain
急性至慢性口面部疼痛转变的模型和机制
- 批准号:
7805658 - 财政年份:2009
- 资助金额:
$ 7.17万 - 项目类别:
Optoid Analgesics: Modulation of Trigeminal & Spinal Glial Activation
Optoid 镇痛药:三叉神经的调节
- 批准号:
7840785 - 财政年份:2009
- 资助金额:
$ 7.17万 - 项目类别:
Exploring the Potential of Glia for Regulating Clinically Relevant Opiod Actions
探索神经胶质细胞调节临床相关阿片类药物作用的潜力
- 批准号:
8267435 - 财政年份:2008
- 资助金额:
$ 7.17万 - 项目类别:
相似海外基金
Planning Study for the Development of Sigma 2 ligands as Analgesics
Sigma 2 配体镇痛药开发规划研究
- 批准号:
10641500 - 财政年份:2023
- 资助金额:
$ 7.17万 - 项目类别:
Designing and validating optimal nonaddictive analgesics using the CANDO paradigm
使用 CANDO 范式设计和验证最佳的非成瘾性镇痛药
- 批准号:
10485593 - 财政年份:2023
- 资助金额:
$ 7.17万 - 项目类别:
Identification of botanical hHv1 channel blockers as analgesics for neuropathic pain
植物 hHv1 通道阻滞剂作为神经性疼痛镇痛药的鉴定
- 批准号:
10728526 - 财政年份:2023
- 资助金额:
$ 7.17万 - 项目类别:
Designed Multiple Ligands as Non-opioid Analgesics for Treating Chronic Pain
设计多种配体作为非阿片类镇痛药,用于治疗慢性疼痛
- 批准号:
10621646 - 财政年份:2023
- 资助金额:
$ 7.17万 - 项目类别:
Elucidation of the mechanism of pain suppression by exercise and development of new analgesics
阐明运动镇痛机制及开发新型镇痛药
- 批准号:
22K19602 - 财政年份:2022
- 资助金额:
$ 7.17万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Single-administration microneedles with controlled sustained release of non-opioid analgesics to treat osteoarthritis pain
单次给药微针控制缓释非阿片类镇痛药治疗骨关节炎疼痛
- 批准号:
10425794 - 财政年份:2022
- 资助金额:
$ 7.17万 - 项目类别:
Allosteric Targeting of Cannabinoid CB1 Receptor to Develop Non-Addictive Small Molecule Analgesics
大麻素 CB1 受体变构靶向开发非成瘾性小分子镇痛药
- 批准号:
10512672 - 财政年份:2022
- 资助金额:
$ 7.17万 - 项目类别:
A novel clinically-relevant mouse model of chronic overlapping pain conditions for screening analgesics
用于筛选镇痛药的新型临床相关慢性重叠疼痛小鼠模型
- 批准号:
10821681 - 财政年份:2022
- 资助金额:
$ 7.17万 - 项目类别:
Single-administration microneedles with controlled sustained release of non-opioid analgesics to treat osteoarthritis pain
单次给药微针控制缓释非阿片类镇痛药治疗骨关节炎疼痛
- 批准号:
10721752 - 财政年份:2022
- 资助金额:
$ 7.17万 - 项目类别: